Seminars in Colon & Rectal Surgery
Volume 19, Issue 4 , Pages 203-206, December 2008

Chemotherapeutic Strategies for Resectable Colorectal Liver Metastases

  • David P. Ryan, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to David P. Ryan, MD, Assistant Professor in Medicine, Tucker Gosnell Gastrointestinal Cancer Center, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Boston, MA 02114

Tucker Gosnell Gastrointestinal Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts

Colon cancer remained the third leading cause of death in the United States for both men and women in 2008. Of the patients who develop metastatic disease, approximately 60% will present with metachronous disease and 40% will present with synchronous disease.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1043-1489(08)00054-7

doi:10.1053/j.scrs.2008.09.004

Seminars in Colon & Rectal Surgery
Volume 19, Issue 4 , Pages 203-206, December 2008

Article Tools